Press release
Cardiac Biomarkers Market 2020-2026: Market Share, Applications, Growth Trends and Forecast Report
Cardiac Biomarkers Market
For More Information in the Analysis of Report: https://www.fortunebusinessinsights.com/industry-reports/cardiac-biomarkers-market-101233
Persistent Technological Advancement for Developing Biomarkers to Drive Global Market
Fortune Business Insights states in the report that the main reason behind the ever-increasing demand for cardiac biomarkers is because of the rising incidence of cardiovascular diseases, which, in turn, is increasing the demand for early detection of the diseases. Moreover, innovative product launches by prominent market players and increasing fast track approvals are expected to drive the global cardiac biomarkers market growth in the forecast period. Also, a rise in the technological advancements in the field of cardiac biomarkers and increasing demand for point of care testing kits are likely to contribute to the global market growth in the upcoming years.
Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/cardiac-biomarkers-market-101233
Key Companies and Manufacturers Covered:
• Thermo Fisher Scientific
• Abbott
• Becton
• Bio-Rad Laboratories, Inc.
• F. Hoffmann-La Roche Ltd.
• Randox Laboratories Ltd.
• Beckman Coulter, Inc.
• Dickinson and Company
• Dickinson and Company
• bioMérieux SA
• Other key market players
Siemens and Roche Receive FDA Clearance for Their Products to Aid in Early Detection of Heart Attack
Siemens Healthineers, a prominent healthcare company, based in Germany, announced in July 2018 that it bagged FDA approval for high-sensitivity troponin I assays (TnIH). They would be used on the company’s Advia Centaur XP/XPT as well as Atellica IM immunoassay analyzers. It would further support in the early diagnosis of heart attacks or myocardial infarctions. Siemens declared that the two TnIH assays possess high sensitivity. Therefore, it would aid in detecting minute changes in troponin levels in patients as well as finding lower levels of troponin. The testing has to be conducted repeatedly to achieve the desired results. That is why doctors and clinicians would gain more confidence in the results and immediately begin treatment of the same.
Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/cardiac-biomarkers-market-101233
Cardiac Biomarkers Market Segmentation:
By Type
• Troponin
• Creatine kinase-MB (CK-MB)
• B-type Natriuretic Peptide (BNP), and N-terminal pro b-type natriuretic peptide (NT-proBNP)
• Myoglobin
• Others
By Application
• Acute Coronary Syndrome
• Myocardial Infarction
• Congestive Heart Failure
• Others
By End User
• Hospitals
• Diagnostic Centers
• Homecare Settings
• Others
By Geography
• North America (USA and Canada)
• Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
• Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
• Latin America (Brazil, Mexico and Rest of Latin America)
• Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)
Order Full Report: https://www.fortunebusinessinsights.com/checkout-page/101233
Our proven methodologies and systematic analysis help in making confident business and strategic decisions.
A market study that conducts at Fortune Business Insights can save significant cost and time, and can help prevent making costly mistakes.
About Us:
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
Contact Us:
Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.
Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
Linkedin | Twitter | BLogs
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cardiac Biomarkers Market 2020-2026: Market Share, Applications, Growth Trends and Forecast Report here
News-ID: 2126684 • Views: …
More Releases from Fortune Business Insights Private Limited
![Forensic Technology Market Size, Share, Trends, Growth & Industry Overview [2025-2032]](https://cdn.open-pr.com/L/5/L522889944_g.jpg)
Forensic Technology Market Size, Share, Trends, Growth & Industry Overview [2025 …
Forensic Technology Market: Trends, Growth, and Key Players in 2025
Market Overview
The forensic technology market is undergoing a transformative evolution driven by advancements in AI, digitalization, and increasing global crime rates. From crime scene investigation to DNA analysis and digital forensics, modern forensic tools are revolutionizing law enforcement and judicial systems. As governments and private entities invest heavily in advanced forensic solutions, the market is poised for robust growth through 2032.…
Dental Market Size, Share, Trends & Growth Report, 2032
The global dental market size was valued at USD 37.86 billion in 2024. The market is projected to grow from USD 41.03 billion in 2025 to USD 87.65 billion by 2032, exhibiting a CAGR of 11.5% during the forecast period. North America dominated the dental market with a market share of 39.06% in 2024.
The dental market refers to the industry that encompasses all businesses, products, and services related to oral…
Contraceptives Market Growing Rapidly With a CAGR of 5.5% by 2027
🌍 Contraceptives Market: Global Industry Insights, Trends & Forecast to 2027
🤖 Market Overview
The global contraceptives market has seen consistent growth over the past decade, driven by increased awareness around reproductive health, government initiatives promoting family planning, and technological advancements in birth control methods. As we move toward 2027, the market is projected to witness significant expansion, presenting lucrative opportunities for stakeholders, manufacturers, and investors.
This article offers a comprehensive analysis of…
Smart Inhalers Market Size, Share, Growth & Industry Report (2025-2032)
🌐 Market Overview
The smart inhalers market is poised for exponential growth, driven by increasing respiratory disorders, advancements in digital health, and the demand for personalized treatment. Smart inhalers, equipped with sensors and Bluetooth technology, help patients track dosage, adherence, and treatment effectiveness in real time. These devices are increasingly integrated with mobile health apps, improving both patient outcomes and physician monitoring. With healthcare systems shifting toward remote patient management, smart…
More Releases for Biomarkers
Biomarkers Market Soars: Safety Biomarkers Lead with 15.9% Projected Growth from …
The global biomarkers market size was valued at US$ 59.1 Billion in 2021 and is expected to expand at a compound annual growth rate CAGR of 15.3% from 2022 to 2032. Safety Biomarkers are expected to be the highest revenue generating biomarker type, with a projected growth of 15.9% from 2022-2032.
Biomarkers, or biological indicators, have revolutionized the fields of medicine and healthcare by enabling early disease detection, personalized treatment, and…
Neurological Biomarkers Market - Decoding Brain Health: Biomarkers Revolutionizi …
Newark, New Castle, USA: The "Neurological Biomarkers Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Neurological Biomarkers Market: https://www.growthplusreports.com/report/neurological-biomarkers-market/8040
This latest report researches the industry structure, sales, revenue,…
Cardiac Biomarkers Market - Unveiling Heart Health: Biomarkers Revolutionizing C …
Newark, New Castle, USA: The "Cardiac Biomarkers Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Cardiac Biomarkers Market: https://www.growthplusreports.com/report/cardiac-biomarkers-market/8024
This latest report researches the industry structure, sales, revenue,…
Global Companion Diagnostic Cancer Biomarkers Market by types (Protein Biomarker …
Global Companion Diagnostic Cancer Biomarkers Market Research Report” Purchase This Report by calling ResearchnReports.com at +1-888-631-6977.
The report, titled Companion Diagnostic Cancer Biomarkers presents an in-depth study of the Companion Diagnostic Cancer Biomarkers market. Providing a brief history about the market, the report analyses the entire value chain of the market and points out the key drivers and restraints affecting the growth of the market during the forecast period. The report…
Global Biomarkers Market Propelled by Growing Usage of Biomarkers in Medical Are …
A biomarker refers to a biological molecule or gene that is used to effectively and accurately evaluate pharmacologic responses, pathogenic procedures, and biological procedures. Also known as a molecular marker or signature molecule, biomarkers are found in blood, other body fluids, and tissue. Extensively used to see the body’s response to a particular treatment for a disease or condition, biomarkers assist medical professionals to take effective clinical decisions and help…
Biomarkers Summit
SMi present their 4th annual conference on
Biomarkers Summit
Monday 31st January & Tuesday 1st February 2011
Crowne Plaza The-City, London, UK
Don’t Miss Out - Visit to register your place today
http://www.smi-online.co.uk/preclinical-biomarkers.asp
Sponsored by
Caprotec
Cell Signalling Technology
GVK Bio
Selventa
Millipore Quest Diagnostics
RBM
SMi’s highly anticipated 4th annual Biomarkers Summit is fast approaching, and time is running out…
